Human Anti-Oxidation Protein A1M—A Potential Kidney Protection Agent in Peptide Receptor Radionuclide Therapy

Human Anti-Oxidation Protein A1M—A Potential Kidney Protection Agent in Peptide Receptor Radionuclide Therapy

Peptide receptor radionuclide therapy (PRRT) has been in clinical use for 15 years to treat metastatic neuroendocrine tumors. PRRT is limited by reabsorption and retention of the administered radiolabeled somatostatin analogues in the proximal tubule. Consequently, it is essential to develop and emp...

Full description

Bibliographic Details
Main Authors: Jonas Ahlstedt, Thuy A. Tran, Sven-Erik Strand, Magnus Gram, Bo Åkerström
Format: Article
Language:English
Published: MDPI AG 2015-12-01
Series:International Journal of Molecular Sciences
Subjects:
A1M
radioprotection
octreotide
PRRT
oxidative stress
antioxidation
kidney
glomerulus
tubule
Online Access:http://www.mdpi.com/1422-0067/16/12/26234

Internet

http://www.mdpi.com/1422-0067/16/12/26234

Similar Items